|
STEMI: Primary PCI |
|
Primary PCI: ALKK PTCA in stable survivors of acute MI vs medical therapy
BRAVE-2 Benefit of primary PCI among asymptomatic pts presenting late in STEMI
CADILLAC Abciximab & Bare Metal Stenting in STEMI
CAPTIM Comparison of Angioplasty and Prehospital Thrombolysis in Acute Myocardial Infarction
DANAMI II Danish Myocardial Infarction Study
MATE from Peter McCullough, M.D., Medicine vs Angiography in Thrombolytic (Reperfusion) Exclusion Patients
PAMI Stent: Mortality among patients with a closed artery on presentation to cath lab |
Facilitated PCI: ADMIRAL Abciximab pre-PCI for STEMI
ADVANCE Additive value of tirofiban administered with the high-dose bolus in the prevention of ischemic complications during high-risk coronary angioplasty *Provided by Dr. Valgimigli, University of Ferrara Italy & Erasmus MC, the Netherlands
CAPITAL AMI Combined Angioplasty and Pharmacological Intervention Versus Thrombolytics Alone in Acute Myocardial Infarction
GRACIA-2 Safety and efficacy of optimal primary PCI vs facilitated PCI with TNK+stenting in patients with ST elevation MI
INTAMI Integrilin in Acute Myocardial Infarction
PACT Half dose tPA before PCI in STEMI
REACT Rescue Angioplasty Versus Conservative Therapy or Repeat Thrombolysis Trial
STRATEGY Single High-Dose Bolus Tirofiban and Sirolimus-Eluting Stent vs. Abciximab and Bare-Metal Stent in Myocardial Infarction
TETAMI Treatment of Enoxaparin and Tirofiban in Acute Myocardial Infarction
TIGER PA Aggrastat before primary PCI |
Distal Protection:
AiMI Thrombectomy With the AngioJet in Acute Myocardial Infarction
EMERALD Enhanced Myocardial Efficacy and Removal by Aspiration of Liberated Debris
Filterwire FilterWire-Ex as an Adjunct to Primary PCI |